<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="136208">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01952080</url>
  </required_header>
  <id_info>
    <org_study_id>TED-C13-003</org_study_id>
    <nct_id>NCT01952080</nct_id>
  </id_info>
  <brief_title>A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome</brief_title>
  <official_title>A 12-Week Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects Aged 1 Year Through 17 Years, With Short Bowel Syndrome Who Are Dependent on Parenteral Support</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>NPS Pharmaceuticals</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>NPS Pharmaceuticals</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This will be an open label, 4-cohort study. Non-randomized subjects will receive teduglutide
      in each of the 3 active cohorts. An attempt will be made to enroll additional subjects into
      an observational cohort who will receive standard of care. Three doses of teduglutide are to
      be investigated for 12 weeks. All subjects will be screened prior to the start of treatment
      (SOT) to establish baseline characteristics including safety, eligibility and nutritional
      support parameters.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2013</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Safety</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Number of reported adverse events after 12 weeks of teduglutide</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pharmacodynamics</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in parenteral support requirements after 12 weeks of teduglutide (liters/week)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pharmacodynamics</measure>
    <time_frame>12 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Change in enteral support requirements after 12 weeks of teduglutide (liters/week)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">36</enrollment>
  <condition>Short Bowel Syndrome</condition>
  <arm_group>
    <arm_group_label>teduglutide</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Open label teduglutide, subcutaneously injected.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>teduglutide</intervention_name>
    <arm_group_label>teduglutide</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Key Inclusion Criteria:

          -  Current history of SBS as a result of major intestinal resection, (eg, due to
             necrotizing enterocolitis, midgut volvulus, intestinal atresia, or gastroschisis) for
             at least 12 months prior to screening

          -  Short bowel syndrome that requires parenteral nutrition/intravenous (PN/IV) support

          -  Stable PN/IV support for at least 3 months prior to enrollment based upon the opinion
             of the investigator

        Key Exclusion Criteria:

          -  Serial transverse enteroplasty or any other bowel lengthening procedure performed
             within the past 3 months

          -  Unstable absorption due to cystic fibrosis, untreated Hirschsprung's disease or known
             DNA abnormalities (ie, Familial Adenomatous Polyposis, Fanconi syndrome)

          -  Evidence of obstruction on upper gastrointestinal (GI) series done within 6 months
             prior to screening

          -  Major gastrointestinal surgical intervention within 3 months prior to screening
             (insertion of feeding tube or endoscopic procedure is allowed)
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>17 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Executive Director Clinical Development, GI</last_name>
    <role>Study Director</role>
    <affiliation>NPS Pharmaceuticals</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Operations</last_name>
    <phone>908-450-5300</phone>
    <email>info@npsp.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>ChildrenÂ´s of Alabama</name>
      <address>
        <city>Brimingham</city>
        <state>Alabama</state>
        <zip>35233</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Donna Bartle</last_name>
      <phone>205-638-2925</phone>
    </contact>
    <investigator>
      <last_name>Reed Dimmitt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Arkansas Children's Hospital</name>
      <address>
        <city>Little Rock</city>
        <state>Arkansas</state>
        <zip>72202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Hart</last_name>
      <phone>501-364-4490</phone>
    </contact>
    <investigator>
      <last_name>Juliana Vaughan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mattel Children's Hospital UCLA, Department of Pediatric Gastroenterology</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90095</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Susan Feist</last_name>
      <phone>310-825-4349</phone>
    </contact>
    <investigator>
      <last_name>Robert Venick, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rady Children's Hospital- San Diego</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92123</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Katheryn Smith</last_name>
      <phone>858-966-8152</phone>
    </contact>
    <investigator>
      <last_name>Rebecca Cherry, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ann &amp; Robert H. Lurie Children's Hospital of Chicago</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristen Johnson</last_name>
      <phone>312-227-4200</phone>
    </contact>
    <investigator>
      <last_name>Valeria Cohran, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Riley Hospital for Children at IU Health</name>
      <address>
        <city>Indianapolis</city>
        <state>Indiana</state>
        <zip>46202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann Klipsch</last_name>
      <phone>317-944-9605</phone>
    </contact>
    <investigator>
      <last_name>Charles P Vanderpool, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Boston Children's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sivan Kassiff</last_name>
      <phone>617-730-0494</phone>
    </contact>
    <investigator>
      <last_name>Christopher Duggan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Mott Children's Hospital, University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ann M Mehringer</last_name>
      <phone>734-936-8464</phone>
    </contact>
    <investigator>
      <last_name>Daniel H Teitelbaum, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Childrens Mercy Hospitals &amp; Clinics Pediatric Gastroenterology</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64108</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Corey Schurman</last_name>
      <phone>816-802-1167</phone>
    </contact>
    <investigator>
      <last_name>Joel Lim, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68198</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bridget Bauman</last_name>
      <phone>402-559-6955</phone>
    </contact>
    <investigator>
      <last_name>David Mercer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Montefiore Medical Center</name>
      <address>
        <city>Bronx</city>
        <state>New York</state>
        <zip>10467</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gaelle Erisnor</last_name>
      <phone>718-741-2557</phone>
    </contact>
    <investigator>
      <last_name>John F Thompson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Cincinnati Children's Hospital Medical Center</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45229</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Crystal Slaughter</last_name>
      <phone>513-636-0137</phone>
    </contact>
    <investigator>
      <last_name>Samuel Kokoshis, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Conrad Cole, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Tennessee Health Science Center Le Bonheur Pediatric Specialists</name>
      <address>
        <city>Memphis</city>
        <state>Tennessee</state>
        <zip>38103</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ila MacDonald</last_name>
      <phone>901-287-5366</phone>
    </contact>
    <investigator>
      <last_name>Mark Corkin, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Monroe Carell, Jr. Children's Hospital at Vanderbilt</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37232</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cynthia Womack-Ramirez</last_name>
      <phone>615-322-4137</phone>
    </contact>
    <investigator>
      <last_name>Kelly Thomsen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Texas Children's Hospital, Baylor College of Medicine</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Brooke Bessard</last_name>
      <phone>832-824-4267</phone>
    </contact>
    <investigator>
      <last_name>Beth Carter, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Seattle Childrens Hospital Gastroenterology and Hepatology</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Heather Vendettuoli</last_name>
      <phone>206-987-0055</phone>
    </contact>
    <investigator>
      <last_name>Simon Horslen, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Wisconsin School of Medicine and Public Health Surgery</name>
      <address>
        <city>Madison</city>
        <state>Wisconsin</state>
        <zip>53792</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lauren Howard</last_name>
      <phone>608-265-6648</phone>
    </contact>
    <investigator>
      <last_name>Peter F Nichol, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 16, 2014</lastchanged_date>
  <firstreceived_date>September 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Short Bowel Syndrome</keyword>
  <keyword>SBS</keyword>
  <keyword>Pediatric SBS</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Short Bowel Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
